Cargando…
Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids
The Toll-like receptor 4 (TLR4)/myeloid differentiation factor 2 (MD-2) complex is a key receptor of the innate immune system and a major driver of inflammation that is responsible for the multifaceted defense response to Gram-negative infections. However, dysfunction in the tightly regulated mechan...
Autores principales: | Borio, Alessio, Holgado, Aurora, Passegger, Christina, Strobl, Herbert, Beyaert, Rudi, Heine, Holger, Zamyatina, Alla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459247/ https://www.ncbi.nlm.nih.gov/pubmed/37630200 http://dx.doi.org/10.3390/molecules28165948 |
Ejemplares similares
-
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
por: Cochet, Florent, et al.
Publicado: (2019) -
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
por: Strobl, Sebastian, et al.
Publicado: (2022) -
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics
por: Adanitsch, Florian, et al.
Publicado: (2018) -
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics
por: Heine, Holger, et al.
Publicado: (2022) -
Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold
por: Garate, Jose Antonio, et al.
Publicado: (2015)